The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
28 September 2026 · selank · peptides · research · australia · regulation
Selank research suggests nasal and injected dosing hit different receptors in mice. What the evidence shows, and Selank's legal status in Australia.
Read more →26 September 2026 · selank · peptides · research · australia · nootropics
Selank research in two mouse strains: effects appeared only in anxious BALB/c mice, and route changed the profile. Plus is Selank legal in Australia?
Read more →23 September 2026 · selank · peptides · nootropics · research · australia
What is Selank? The newest research is a 2026 rat gene-expression study, not a trial - plus Selank's legal status in Australia, clearly explained.
Read more →20 September 2026 · selank · peptides · immunology · research · australia
Selank began as an immune peptide, not an anxiolytic. What is Selank, what the IL-6 and antiviral research really shows, and its Australian legal status.
Read more →17 September 2026 · selank · peptides · anxiety · clinical-trials · tga
What is Selank? Its anxiety reputation rests on three small Russian trials, none placebo-controlled. The evidence, the 37% problem, and Selank's Australia status.
Read more →15 September 2026 · selank · peptides · nootropics · pharmacokinetics · australia
What Selank research really shows about nose-to-brain delivery: 0.16% of an intranasal dose in rat brain, no human PK data, and Selank's status in Australia.
Read more →12 September 2026 · selank · peptides · research · australia · regulation
Selank is marketed for anxiety, yet much of its research is immunological. What the Selank research actually shows - and its legal status in Australia.
Read more →9 September 2026 · selank · peptides · anxiety · tga · research
What is Selank? The 2015 Russian trial tested it alongside a benzodiazepine, not instead of one. The real evidence, plus Selank's legal status in Australia.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.